Matches in Nanopublications for { ?s ?p "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP344955.RAA-INkMtQOCC2A7Oem02wZ_wN6-PnlT0d-bxJxz1yKPY130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344955.RAA-INkMtQOCC2A7Oem02wZ_wN6-PnlT0d-bxJxz1yKPY130_provenance.
- NP72951.RACCVJQ4IoByXmcr_1np2hLlB_jzcqreoiUluOjfhG3Bc130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72951.RACCVJQ4IoByXmcr_1np2hLlB_jzcqreoiUluOjfhG3Bc130_provenance.
- NP82162.RA1QHEjL0w5mf44ZVoVRZc2_8xKv8WMohTQIij3Gpyjr4130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82162.RA1QHEjL0w5mf44ZVoVRZc2_8xKv8WMohTQIij3Gpyjr4130_provenance.
- NP540438.RAPwANEUuiqQExnEkYXDdc6bW6Aj3TrH-8l7UAxVbqHFM130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540438.RAPwANEUuiqQExnEkYXDdc6bW6Aj3TrH-8l7UAxVbqHFM130_provenance.
- NP540769.RAJmbHHMq-X7uY4hq5IaVY-M8jvYvrNVZIJaRB_lIphrg130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540769.RAJmbHHMq-X7uY4hq5IaVY-M8jvYvrNVZIJaRB_lIphrg130_provenance.
- NP344953.RAxc9nuKs_plqokD6Dy-j6f1VJW751lCdyPpaMwX4nMEA130_assertion description "[These results indicate that TNFB has both tumorigenic and antitumorigenic capabilities depending on the genotype: the TNFB SNP TNFB*G/TNFB*G genotype gave an increased risk for breast cancer and that of TNFB*A/TNFB*A gave resistance to breast cancer (OR = 5.3395%; CI: 2.33-12.19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344953.RAxc9nuKs_plqokD6Dy-j6f1VJW751lCdyPpaMwX4nMEA130_provenance.